Key result
Drug-coated balloons remain a key therapeutic strategy for managing in-stent restenosis.
Answers are grounded in this paper and cite their sources.
Supports drug-coated balloons for in-stent restenosis; leaves open need for randomized trials to confirm benefits.
Graphical abstractDisplay full size
No takes yet. Share an insight, caveat, or question.
Milzi et al. (2026) studied this question. Drug-coated balloons remain a key contemporary therapeutic strategy for managing in-stent restenosis according to current clinical evidence.
Synapse has enriched 10 related papers. Consider them for comparative context: